ImmuCell Corporation (ICCC) Social Stream
IMMUCELL CORP (ICCC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ICCC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-02-15 | 1 | $14 | $14 | $14 | $4.95 | 182.83% |
| NA | 1 | $NA | $NA | $NA | $4.95 | NA% |
Price Target Last Issued February 15, 2021
The Trend in the Analyst Price Target
ICCC's average price target has moved down $0 over the prior 130 days.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|
ICCC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ICCC as an investment opportunity.
- In terms of how IMMUCELL CORP fares relative to all US stocks, note that its number of analysts covering the stock is higher than just about none of of that group.
- IMMUCELL CORP's variance in analysts' estimates is lower than almost 100% of all US stocks.
- ICCC has a greater average analyst price target than 25.04% of Healthcare stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, IMMUCELL CORP's upside potential (average analyst target price relative to current price) is greater than 65.73% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IMMUCELL CORP are VNRX, ABVC, and PCSA.
View All Top Stocks by Price Target
Is ICCC a Buy, Hold or Sell? See the POWR Ratings now!